These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 11460820)

  • 1. Cheap HIV drugs for developing countries.
    Int J Epidemiol; 2001 Jun; 30(3):651-2. PubMed ID: 11460820
    [No Abstract]   [Full Text] [Related]  

  • 2. "No turning back" on cheap AIDS drugs for poor nations, UN vows.
    Silversides A
    CMAJ; 2003 Nov; 169(10):1067. PubMed ID: 14609992
    [No Abstract]   [Full Text] [Related]  

  • 3. Laboratory monitoring of HIV--after access to antiretroviral drugs, the next challenge for the developing world.
    Tucker T; Yeats J
    S Afr Med J; 2001 Aug; 91(8):615. PubMed ID: 11584766
    [No Abstract]   [Full Text] [Related]  

  • 4. Improving access to essential drugs for people living with HIV/AIDS.
    Balasubramaniam K
    Issues Med Ethics; 2000; 8(1):26-7. PubMed ID: 16323335
    [No Abstract]   [Full Text] [Related]  

  • 5. Affordable drug access for developing countries.
    Highleyman L
    BETA; 2001; 14(2):12-25. PubMed ID: 11785481
    [No Abstract]   [Full Text] [Related]  

  • 6. Working together to provide generics for health.
    Beck EJ; Reiss P
    Antivir Ther; 2014; 19 Suppl 3():1. PubMed ID: 25310234
    [No Abstract]   [Full Text] [Related]  

  • 7. Access to HIV drugs: are we changing the two world paradigm?
    Lazzarini Z
    Conn J Int Law; 2002; 17(2):281-96. PubMed ID: 12688297
    [No Abstract]   [Full Text] [Related]  

  • 8. Tripping over patents: AIDS, access to treatment and the manufacturing of scarcity.
    Berger JM
    Conn J Int Law; 2002; 17(2):157-248. PubMed ID: 12688292
    [No Abstract]   [Full Text] [Related]  

  • 9. Commentary: the reality of treating HIV and AIDS in poor countries.
    Sykes R
    BMJ; 2002 Jan; 324(7331):216-7. PubMed ID: 11831203
    [No Abstract]   [Full Text] [Related]  

  • 10. TRIPS post-2005 and access to new antiretroviral treatments in southern countries: issues and challenges.
    Orsi F; D'Almeida C; Hasenclever L; Camara M; Tigre P; Coriat B
    AIDS; 2007 Oct; 21(15):1997-2003. PubMed ID: 17885289
    [No Abstract]   [Full Text] [Related]  

  • 11. Initiative to promote access to quality HIV medicines releases first batch of results today.
    J Adv Nurs; 2002 Aug; 39(3):215. PubMed ID: 12174834
    [No Abstract]   [Full Text] [Related]  

  • 12. Closing the affordability gap for drugs in low-income countries.
    Steinbrook R
    N Engl J Med; 2007 Nov; 357(20):1996-9. PubMed ID: 18003957
    [No Abstract]   [Full Text] [Related]  

  • 13. A one-time-only combination: Emergency medicine exports and the TRIPS agreement under Canada's access to medicines regime.
    Weber A; Mills L
    Health Hum Rights; 2010 Jun; 12(1):109-22. PubMed ID: 20930258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. World Trade Organization still threatens supply of affordable AIDS drugs.
    Hagmann M
    Bull World Health Organ; 2002; 80(9):762-3. PubMed ID: 12378300
    [No Abstract]   [Full Text] [Related]  

  • 15. Tobias, W.H.O. at odds over drug standards.
    Med Health; 2004 Mar; 58(13):2-3. PubMed ID: 15088496
    [No Abstract]   [Full Text] [Related]  

  • 16. HIV/AIDS: Latin America & Caribbean. Brazil: ten years after.
    Cohen J
    Science; 2006 Jul; 313(5786):484-7. PubMed ID: 16873654
    [No Abstract]   [Full Text] [Related]  

  • 17. [HIV therapy: tenofir DF is available in 68 developing countries at production costs price].
    Med Klin (Munich); 2003 Jul; 98(7):XV-XVI. PubMed ID: 12945544
    [No Abstract]   [Full Text] [Related]  

  • 18. Ensuring access to essential medicines: some economic considerations.
    Maskus KE
    Spec Law Dig Health Care Law; 2003 Jul; (291):9-25. PubMed ID: 15206162
    [No Abstract]   [Full Text] [Related]  

  • 19. TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha.
    't Hoen E
    Chic J Int Law; 2002; 3(1):27-46. PubMed ID: 15709298
    [No Abstract]   [Full Text] [Related]  

  • 20. Dose reduction of antiretrovirals: a feasible and testable approach to expand HIV treatment in developing countries.
    Vento S; Lanzafame M; Lattuada E; Cainelli F; Restelli U; Foglia E
    Trop Med Int Health; 2013 Jan; 18(1):40-4. PubMed ID: 23094787
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.